TAKE THIS POLL |
|
|
- Merck ties up with Welcome Trust to develop vaccines 8 Nov 2009 07:30 GMT
... Merck ties up with Welcome Trust to develop vaccines NEW DELHI: Drug firm Merck & Co on ...
- AIDS drug development a long haul 8 Nov 2009 07:51 GMT
... drug, one that could help save lives and reap huge profits for her employer, Merck & Co. Inc. Daria Hazuda, who led the development of Isentress, and Steven Young, who worked with ...
- New Survey Reveals Unmet Needs In Asthma Care In The U.S. 8 Nov 2009 09:18 GMT
... M.D.; and Stuart Stoloff, M.D. The survey was sponsored by Schering Corporation; Schering-Plough and Merck & Co. Inc. merged on November 3, 2009. Today's Merck is working to help the world be ...
- FACTBOX-Health company winners, losers in US House bill 8 Nov 2009 05:20 GMT
... secretary to negotiate drug prices under Medicare. Drugmakers, which include Pfizer Inc, GlaxoSmithKline Plc, Merck & Co Inc and others, have opposed both ideas. The House bill would gradually eliminate the Medicare ...
- FACTBOX - Health company winners, losers in U.S. House bill 8 Nov 2009 05:53 GMT
... secretary to negotiate drug prices under Medicare. Drugmakers, which include Pfizer Inc, GlaxoSmithKline Plc, Merck & Co Inc and The House bill would gradually eliminate the Medicare "doughnut hole," when prescription drug ...
- Merck poised for more growth 8 Nov 2009 09:20 GMT
... TRENTON, N.J. - The new Merck & Co. has become the world's second-biggest drugmaker overnight with a huge acquisition, but it still has ...
- Drugs that work and won't break the bank 8 Nov 2009 01:56 GMT
... scientific name. Many patients are familiar with Merck's cholesterol-lowering pill Zocor, but they might not ... out to be unsafe is Merck's painkiller Vioxx, which was pulled from the market in 2004 ...
- Prescription drugs that work and won't break the bank 8 Nov 2009 05:20 GMT
... scientific name. Many patients are familiar with Merck's cholesterol-lowering pill Zocor, but they might not ... out to be unsafe is Merck's painkiller Vioxx, which was pulled from the market in 2004 ...
- Gloucester's Istodax Wins Nod; No Partner Yet for CTCL Drug 7 Nov 2009 01:16 GMT
... CTCL in the U.S. - Eisai Inc's antibiotic Ontak and retinoic acid Targretin and Merck & Co. Inc's Zolinza (vorinostat), a histone deacetylase (HDAC) inhibitor. Romidepsin also is an HDAC inhibitor, but ...
- Merck & Co. Inc. Gets Multiple Rating Actions; Schering-Plough Ratings Raised, Off Watch 5 Nov 2009 20:31 GMT
... Merck & Co. Inc. Gets Multiple Rating Actions; Schering-Plough Ratings Raised, Off Watch --U.S. pharmaceutical giant Merck completed ...
- Nuevolution Announces Receipt of Milestone Payment From Merck & Co., Inc. 2 Nov 2009 10:10 GMT
... Nuevolution Announces Receipt of Milestone Payment From Merck & Co., Inc. /PRNewswire/ -- Nuevolution A/S today announced that it has received a milestone payment ...
- Trading Outlook for Novavax Inc. Issued by InvestorSoup.com 4 Nov 2009 12:16 GMT
... Inc. (Nasdaq:NVAX) should be of particular interest to other biotechnology companies: Novartis AG (NYSE:NVS), Merck & Co. Inc. (NYSE:MRK) and Teva Pharmaceutical Industries Ltd. (Nasdaq:TEVA). Get our alerts BEFORE the rest of ...
- Updates for Merck & Co. (NYSE:MRK), Advanced Cell Technology (OTC:CTC), Catalyst (NASDAQ:CHSI) 5 Nov 2009 05:33 GMT
... Updates for Merck & Co. (NYSE:MRK), Advanced Cell Technology (OTC:CTC), Catalyst (NASDAQ:CHSI) Pasadena, CA - 11/04/09 - BioMedReports.Com, the news ...
- BiomedReports: News and FDA Updates for Merck & Co. (NYSE:MRK), Advanced Cell Technology (OTC:CTC), Catalyst (NASDAQ:CHSI) 5 Nov 2009 09:30 GMT
... BiomedReports: News and FDA Updates for Merck & Co. (NYSE:MRK), Advanced Cell Technology (OTC:CTC), Catalyst (NASDAQ:CHSI) Thu. November 05, 2009; Posted: 03:49 AM Pasadena, ...
- Merck & Co now No.2 4 Nov 2009 22:30 GMT
... The new Merck & Co. has become the world's second-biggest drugmaker overnight with a huge acquisition, but it still has ...
- Merck & Co Inc-Financial Company Report - research report released 2 Nov 2009 10:13 GMT
... Merck & Co Inc-Financial Company Report - a new market research report on companiesandmarkets.com Financial Company Reports contain ...
- White House sides with investors in Vioxx lawsuit 2 Nov 2009 07:24 GMT
... Newsline)-The Obama administration has taken the side of investors seeking to sue pharmaceutical giant Merck & Co. over its now-withdrawn blockbuster painkiller Vioxx. In a friend of the court brief filed in the U.S. Supreme Court, President Barack Obama's administration ...
- White House sides with investors in Vioxx lawsuit - 11/2 2 Nov 2009 23:14 GMT
... Newsline)-The Obama administration has taken the side of investors seeking to sue pharmaceutical giant Merck & Co. over its now-withdrawn blockbuster painkiller Vioxx. In a friend of the court brief filed in the U.S. Supreme Court, President Barack Obama's administration ...
- Fitch Downgrades Merck and Upgrades Schering-Plough to 'A+' Following Merger; Outlook Stable 4 Nov 2009 21:11 GMT
... Fitch Downgrades Merck and Upgrades Schering-Plough to 'A+' Following Merger; ... by $1.39 billion of payments into the Vioxx settlement and a $660 million tax settlement during ...
- Feds side with investors in Vioxx suit 2 Nov 2009 22:31 GMT
... filed a brief with the U.S. Supreme Court siding with investors hoping to sue Merck and Co. over its now-withdrawn painkiller Vioxx. In a friend-of-the-court brief, administration officials argued shareholders filed securities lawsuits in a timely manner ...
- Fitch Downgrades Merck and Upgrades Schering-Plough to 'A+' Following Merger; Outlook Stable (BIZ) 4 Nov 2009 21:16 GMT
... billion of debt. Yesterday, the merger of Merck and Schering-Plough was completed for approximately $41.1 ... by $1.39 billion of payments into the Vioxx settlement and a $660 million tax settlement during ...
- Independent Thought on Statins 4 Nov 2009 05:36 GMT
... slightest chance of CHD (Coronary Heart Disease). Merck & Co, the first major manufacturer on ... is incapable of protecting FDA against another Vioxx. British Medical Journal, 27 November 2004. ...
- US midday: Market rebounds after initial decline 6 Nov 2009 18:34 GMT
... Inc. (CSCO) $23.79 -0.59% Boeing Co. (BA) $49.50 -0.54% Pfizer Inc. (PFE) $16.93 -0.53% Merck & Co. Inc. (MRK) $32.55 -0.49% Nasdaq 100 - Risers Nvidia Corp. (NVDA) $13.09 +6.68% Starbucks Corp. ...
- US midday: Dow loses some of its early gains 2 Nov 2009 19:34 GMT
... $59.39 +1.33% General Electric Co. (GE) $14.43 +1.19% Wal-Mart Stores Inc. (WMT) $50.26 +1.17% Merck & Co. Inc. (MRK) $31.29 +1.16% Dow Jones I.A - Fallers AT&T Inc. (T) $25.35 -1.25% Intel ...
- Markets give back gains after Fed comments 4 Nov 2009 23:51 GMT
... 227,000. M B I A Inc. (MBI) $4.42 +7.54% Davita Inc. (DVA) $57.93 +6.49% Merck & Co. Inc. (MRK) $32.64 +6.42% Aetna Inc. (AET) $28.01 +5.22% Cigna Corp. (CI) $29.78 +5.19% Ameriprise ...
1 - 25 of 1042 next >
Powered by 
News by PR Newswire
24-7 pressrelease
Emailwire
|